Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio

Estebán Martínez(Instituto de Salud Carlos III), ML Álvarez(Gilead Sciences (Spain)), Eugènia Negredo(Universitat de Vic - Universitat Central de Catalunya), Vicente Estrada(Instituto de Salud Carlos III), Adrián Curran(Lexington City Schools), Rafael Rubio(Research Institute Hospital 12 de Octubre), Bonaventura Clotet(Universitat de Vic - Universitat Central de Catalunya), Juan Berenguer(Instituto de Salud Carlos III), Sarah Arterburn(Gilead Sciences (United States)), Jesús Sanz(Hospital Universitario de La Princesa), María Larrousse(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Federico Pulido(Bellvitge University Hospital), Pedro Eitz Ferrer(Gilead Sciences (Spain)), Esteban Ribera(Hospital Terrassa)
HIV Medicine
December 11, 2014
10.1111/hiv.12210
Cited by 4

Related Papers

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
|Gastroenterology|2006|882
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
|Gastroenterology|2015|799